| Osteogenesis imperfecta: update on presentation and management MS Cheung, FH Glorieux Reviews in Endocrine and Metabolic Disorders 9, 153-160, 2008 | 220 | 2008 |
| Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo‐controlled study F Rauch, CF Munns, C Land, M Cheung, FH Glorieux Journal of Bone and Mineral Research 24 (7), 1282-1289, 2009 | 145 | 2009 |
| Osteogenesis imperfecta type V: marked phenotypic variability despite the presence of the IFITM5 c.− 14C> T mutation in all patients F Rauch, P Moffatt, M Cheung, P Roughley, L Lalic, AM Lund, N Ramirez, ... Journal of medical genetics 50 (1), 21-24, 2013 | 132 | 2013 |
| Long-bone changes after pamidronate discontinuation in children and adolescents with osteogenesis imperfecta F Rauch, S Cornibert, M Cheung, FH Glorieux Bone 40 (4), 821-827, 2007 | 126 | 2007 |
| International Consensus Statement on the diagnosis, multidisciplinary management and lifelong care of individuals with achondroplasia R Savarirayan, P Ireland, M Irving, D Thompson, I Alves, WAR Baratela, ... Nature Reviews Endocrinology 18 (3), 173-189, 2022 | 98 | 2022 |
| Tooth extraction socket healing in pediatric patients treated with intravenous pamidronate C Chahine, MS Cheung, TW Head, S Schwartz, FH Glorieux, F Rauch The Journal of pediatrics 153 (5), 719-720, 2008 | 95 | 2008 |
| Wormian bones in osteogenesis imperfecta: correlation to clinical findings and genotype O Semler, MS Cheung, FH Glorieux, F Rauch American journal of medical genetics Part A 152 (7), 1681-1687, 2010 | 87 | 2010 |
| Natural history of hyperplastic callus formation in osteogenesis imperfecta type V MS Cheung, FH Glorieux, F Rauch Journal of Bone and Mineral Research 22 (8), 1181-1186, 2007 | 86 | 2007 |
| Abnormalities in muscle density and muscle function in hypophosphatemic rickets LN Veilleux, M Cheung, M Ben Amor, F Rauch The Journal of Clinical Endocrinology & Metabolism 97 (8), E1492-E1498, 2012 | 79 | 2012 |
| Muscle anatomy and dynamic muscle function in osteogenesis imperfecta type I LN Veilleux, M Lemay, A Pouliot-Laforte, MS Cheung, FH Glorieux, ... The Journal of Clinical Endocrinology & Metabolism 99 (2), E356-E362, 2014 | 77 | 2014 |
| Cranial base abnormalities in osteogenesis imperfecta: phenotypic and genotypic determinants MS Cheung, H Arponen, P Roughley, ME Azouz, FH Glorieux, ... Journal of Bone and Mineral Research 26 (2), 405-413, 2011 | 77 | 2011 |
| Cortical and trabecular bone density in X-linked hypophosphatemic rickets M Cheung, P Roschger, K Klaushofer, LN Veilleux, P Roughley, ... The Journal of Clinical Endocrinology & Metabolism 98 (5), E954-E961, 2013 | 73 | 2013 |
| Lifetime impact of achondroplasia: current evidence and perspectives on the natural history J Hoover-Fong, MS Cheung, V Fano, L Hagenas, JT Hecht, P Ireland, ... Bone 146, 115872, 2021 | 69 | 2021 |
| The functional muscle–bone unit in patients with osteogenesis imperfecta type I LN Veilleux, A Pouliot-Laforte, M Lemay, MS Cheung, FH Glorieux, ... Bone 79, 52-57, 2015 | 58 | 2015 |
| The muscle-bone relationship in X-linked hypophosphatemic rickets LN Veilleux, MS Cheung, FH Glorieux, F Rauch The Journal of Clinical Endocrinology & Metabolism 98 (5), E990-E995, 2013 | 50 | 2013 |
| Achondroplasia foramen magnum score: screening infants for stenosis MS Cheung, M Irving, A Cocca, R Santos, M Shaunak, H Dougherty, ... Archives of disease in childhood 106 (2), 180-184, 2021 | 45 | 2021 |
| Management of primary and secondary osteoporosis in children SD Sakka, MS Cheung Therapeutic Advances in Musculoskeletal Disease 12, 1759720X20969262, 2020 | 38 | 2020 |
| Hyperplastic callus formation in osteogenesis imperfecta type V: follow-up of three generations over ten years MS Cheung, EM Azouz, FH Glorieux, F Rauch Skeletal radiology 37 (5), 465-467, 2008 | 35 | 2008 |
| Large osteoclasts in pediatric osteogenesis imperfecta patients receiving intravenous pamidronate MS Cheung, FH Glorieux, F Rauch Journal of Bone and Mineral Research 24 (4), 669-674, 2009 | 34 | 2009 |
| Clinical guidelines for burosumab in the treatment of XLH in children and adolescents: British paediatric and adolescent bone group recommendations R Padidela, MS Cheung, V Saraff, P Dharmaraj Endocrine Connections 9 (10), 1051-1056, 2020 | 30 | 2020 |
